Galera Therapeutics Inc (PK) (GRTX)
USOTC
Year End December 30 2023 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating Income | -24.09M | -24.26M | -50.69M | -70.55M | -73.37M | -51.23M | -49.26M |
Pre Tax Income | -23.91M | -23.9M | -51.94M | -74.23M | -80.53M | -62.29M | -59.08M |
Net Income | -28.13M | -29.59M | -59.11M | -74.22M | -80.53M | -62.22M | -59.08M |
Preferred Dividends | -4.59M | -5.91M | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | -18.509 | -19.464 | -2.382 | -2.972 | -3.044 | -2.182 | -1.086 |
EBIT | -24.09M | -24.26M | -50.69M | -70.55M | -73.37M | -51.23M | -49.26M |
EBITDA | -24.01M | -24.13M | -50.42M | -70.19M | -72.59M | -51.11M | -49M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.